OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹73 Cr | ₹54 Cr | ₹54 Cr | ₹31 Cr | ₹34 Cr |
What is the latest Total Liabilities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹73 Cr |
| Mar2024 | ₹54 Cr |
| Mar2023 | ₹54 Cr |
| Mar2022 | ₹31 Cr |
| Mar2021 | ₹34 Cr |
How is Total Liabilities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹73 Cr | 33.35 | |
| Mar2024 | ₹54 Cr | 0.36 | |
| Mar2023 | ₹54 Cr | 74.06 | |
| Mar2022 | ₹31 Cr | -7.94 | |
| Mar2021 | ₹34 Cr | - | |
Compare Total Liabilities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹221.6 Cr | 3.3% | 10.9% | -26.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -2.8% | -7.5% | -12.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | -0.6% | -5.5% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -2.5% | 3.5% | 21.1% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3.7% | -11.7% | -8.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | -0.7% | -4.7% | -5.1% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | 3.3% |
10.9% |
-26.7% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses